Corbus Pharmaceuticals Holdings, Inc. (CRBP) News Headlines

▮ More

Date

Headline

12/21/2020 5:20:02 AM Pre-market Movers In Healthcare Sector: CBLI, VERO, CRBP, ZOM…

12/1/2020 5:23:14 AM Pre-market Movers In Healthcare Sector: Moderna, ONTX, CRBP, GENE, OPK…

10/8/2020 8:17:11 AM Corbus Pharma Announces Restructuring; To Reallocate Capital - Quick Facts

10/8/2020 8:09:19 AM Corbus Plans Restructuring That Will Result In Reduction Of Workforce By 54%

10/7/2020 3:09:13 AM AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Track

10/6/2020 7:31:09 AM Corbus Pharma Says Phase 2b Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Facts

10/6/2020 7:09:13 AM Corbus Pharma Says Phase 2b Study Of Lenabasum Fails To Meet Primary Endpoint

10/5/2020 6:22:18 AM Pre-market Movers In Healthcare Sector: ENLV, CHFS, EVGN, SLDB, CTIC, VXRT…

9/27/2020 3:57:35 AM Week Ahead In Pharma: Clinical Trial Readouts, FDA Decision (ETON, SELB, CRBP…)

9/9/2020 2:19:17 AM AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL

9/8/2020 7:32:08 AM Corbus Pharma: Lenabasum Phase 3 RESOLVE-1 Trial In SSc Patients Did Not Meet Primary Goal

9/8/2020 7:15:26 AM Corbus Pharma Says RESOLVE-1 Trial Did Not Meet Its Primary Endpoint

9/8/2020 6:51:17 AM Pre-market Movers In Healthcare Sector: ALBO, BIOC, KMDA, BNTX…

9/5/2020 10:04:19 PM Week Ahead In Pharma: Data Readouts, Results From Interim Analysis, ERS Congress Presentation

8/17/2020 6:24:56 AM 5 Biotech Stocks To Watch In The Coming Weeks (ALBO, ALNY, OTLK, MESO, CRBP)

7/8/2020 8:14:51 AM Corbus Pharma Appoints George Golumbeski To Board

7/8/2020 8:07:36 AM Corbus Pharmaceuticals Appoints George Golumbeski To Board

6/22/2020 8:27:51 AM Corbus Says Last Subject Completed Final Visit In Phase 2b JBT101-CF-002 Trial

6/1/2020 8:17:06 AM Corbus Reports Baseline Patient Demographics & Disease Characteristics In Phase 2b Study Of Lenabasum In Cystic Fibrosis

5/27/2020 8:16:17 AM Corbus Pharma Reports Last Subject Visit In RESOLVE-1 Phase 3 Study Of Lenabasum For Systemic Sclerosis